T cell response following anti COVID-19 BNT162b2 vaccination is maintained against the SARS-CoV-2 Omicron B.1.1.529 variant of concern
H. Cohen, S. Rotem, U. Elia, G. Bilinsky, I. Levy, T. Chitlaru, E. Bar-Haim
The study assesses T cell responses to the ancestral and Omicron SARS-CoV-2 spike proteins post-BNT162b2 vaccination, finding comparable reactivity and a dominant Th1 response.
bioRxiv · Jan 19, 2022Immunology